Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancerJia Xu(University of Alabama at Birmingham), Upender Manne(University of Alabama at Birmingham)OncotargetFebruary 21, 201710.18632/oncotarget.15560Cited by 17SaveCiteExport RISWatch citationsRelated PapersVariable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs|BMC Cancer|2014|36